title: The ABCs of RVO: a review of retinal venous occlusion.
abstract: Retinal vein occlusions are important causes of loss of vision; indeed, they are the second most common retinal vascular disease, following diabetic retinopathy. For this reason alone, primary eye-care providers must be well versed in diagnosis and management. Risk factors, though not universally agreed upon, include but are not limited to advancing age, systemic hypertension, arteriolarsclerosis, diabetes, hyperlipidaemia, blood hyperviscosity, thrombophilia, ocular hypertension and glaucoma. Typically, visual loss is secondary to macular oedema and/or retinal ischaemia. Treatment modalities have included observation, systemic thrombolysis and haemodilution, radial optic neurotomy, chorioretinal anastomosis, vitrectomy, laser photocoagulation and intravitreal injection of anti-inflammatory and, most recently, anti-vascular endothelial growth factors.
authors.affiliation: Waterloo, Ontario, Canada. derek.macdonald@rogers.com.
authors.forename: Derek
authors.initials: D
authors.lastname: MacDonald
mesh_terms: D006438:Hemodilution / Q000379:methods*; D006801:Humans; D017075:Laser Coagulation; D012170:Retinal Vein Occlusion / Q000628:therapy*; D015912:Thrombolytic Therapy / Q000379:methods*; D014792:Visual Acuity; D014821:Vitrectomy
keywords: aflibercept; bevacizumab; macular oedema; pegaptanib; ranibizumab; retinal vein occlusion; sheathotomy; vascular endothelial growth factor; vitrectomy